[ Price : $8.95]
The Guardian says CBER director Vinay Prasad successfully had videos of him criticizing Covid vaccines removed from the YouTube ch...[ Price : $8.95]
FDA grants Boehringer Ingelheim a breakthrough therapy designation for Hernexeos (zongertinib) tablets for the first-line treatmen...[ Price : $8.95]
CDER and CBER launch the Rare Disease Evidence Principles process intended to bring greater speed and predictability to the review...[ Price : $8.95]
Memos posted on FDAs Web site from CBER director Vinay Prasad suggest the agency is raising the bar on future Covid-19 vaccination...[ Price : $8.95]
FDA accepts for review an Achieve Life Sciences NDA for cytisinicline, an investigational treatment for helping those seeking to q...[ Price : $8.95]
Reuters reports that drug manufacturers are turning to artificial intelligence to reduce animal testing and cut costs and time in ...[ Price : $8.95]
FDA approves two new denosumab biosimilars from Shanghai Henlius Biotech and Organon for treating osteoporosis and cancer-related ...[ Price : $8.95]
Merck says its oral PCSK9 inhibitor met all primary and secondary endpoints in the CORALreef Lipids Phase 3 trial.